CIK 0001393434
- Large accelerated filer
OCULAR THERAPEUTIX, INC
Sign in to watch- Ticker
- OCUL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 781-357-4000
- Business address
- 14 CROSBY DRIVE, 3RD FLOOR, BEDFORD, MA, 01730
- Former names
- I-THERAPEUTIX INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $799,174
- in 9 filings, $788K under 10b5-1 plans
Net −$799,174. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-31 | Notman Donald Chief Operating Officer | Sale | −1,099 | $10.24 | $11K | 366,529 |
| 2026-02-12 | Notman Donald Chief Operating Officer | Sale | −11,446 | $9.04 | $103K | 366,356 |
| 2026-02-04 | Notman Donald Chief Operating Officer | Sale | −6,035 | $8.54 | $52K | 377,802 |
| 2026-02-02 | Notman Donald Chief Operating Officer | Sale | −5,455 | $9.14 | $50K | 383,837 |
| 2026-01-02 | Notman Donald See Remarks | Grant or award | +79,112 | 389,292 | ||
| 2026-01-02 | Notman Donald See Remarks | Grant or award · Stock Option (Right to Buy) | +240,932 | 240,932 | ||
| 2025-09-02 | Notman Donald See Remarks | Sale | −1,066 | $12.43 | $13K | 308,807 |
| 2025-02-11 | Notman Donald See Remarks | Grant or award | +115,000 | 308,444 | ||
| 2025-02-11 | Notman Donald See Remarks | Grant or award · Stock Option (Right to Buy) | +344,115 | 344,115 | ||
| 2025-02-04 | Notman Donald See Remarks | Sale | −11,119 | $7.81 | $87K | 193,444 |
| 2025-01-31 | Notman Donald See Remarks | Sale | −6,301 | $7.84 | $49K | 204,563 |
| 2024-08-29 | Notman Donald See Remarks | Grant or award | +11,034 | 208,988 | ||
| 2024-08-29 | Notman Donald See Remarks | Grant or award · Stock Option (Right to Buy) | +33,602 | 33,602 | ||
| 2024-02-05 | Notman Donald Chief Financial Officer | Sale | +6,212 | $4.86 | $30K | 195,356 |
| 2024-02-03 | Notman Donald Chief Financial Officer | Grant or award | +61,636 | 201,568 | ||
| 2024-02-03 | Notman Donald Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +185,000 | 185,000 | ||
| 2024-01-31 | Notman Donald Chief Financial Officer | Sale | −6,433 | $4.95 | $32K | 139,932 |
| 2023-02-06 | Notman Donald Chief Financial Officer | Sale | −6,476 | $4.24 | $27K | 139,387 |
| 2023-01-30 | Notman Donald Chief Financial Officer | Grant or award | +55,556 | 145,863 | ||
| 2023-01-30 | Notman Donald Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +166,667 | 166,667 |
Page 1 of 2 · 25 trades